Crews continue their work demolishing the Hoople Special Education Building at 805 South Crouse Avenue on the Syracuse University campus. The City of Syracuse closed the adjacent parking lot in late August to accommodate the demolition work. The City on Tuesday said it would lease a lot on East Adams Street between the KeyBank location and University College for public parking. SU owns the lot and will lease it to the City, according to the news release. (Eric Reinhardt / BJNN)
SYRACUSE, N.Y. — The City of Syracuse will have a new public parking lot in the Syracuse University area beginning Jan. 2.
The new lot is located along East Adams Street between the KeyBank branch office and University College, the City of Syracuse said in a news release issued Tuesday.
It’s replacing the parking lot at the corner of South Crouse Avenue and Marshall Street, which the city closed in late August to accommodate the upcoming construction of the National Veterans Resource Complex.
The City of Syracuse and Syracuse University on Aug. 25 announced they would close the lot to accommodate the demolition work on the Hoople Special Education Building at 805 South Crouse Avenue., which continued Thursday.
Syracuse University, which currently owns the East Adams Street lot, will lease it to the City of Syracuse, which will fit the lot with parking pay stations.
Parking will be available at city rates Monday through Saturday from 9 a.m. to 6 p.m. and it will observe city meter holidays.
Contact Reinhardt at ereinhardt@cnybj.com
WAMPSVILLE, N.Y. — The National Weather Service in Binghamton confirmed Thursday that the damage in…
OSWEGO, N.Y. — A construction project to protect Camp Hollis in the town of Oswego…
UTICA, N.Y. — Mohawk Valley Health System (MVHS) has announced the hiring of William W.…
SYRACUSE, N.Y. — A late Wednesday morning ceremony at Wilson Park in Syracuse included the…
ROME, N.Y. — The city of Rome continues to clean up from a devastating, confirmed…
SYRACUSE, N.Y. — SUNY officials on Monday announced the launch of Upstate Biotech Ventures, a…